Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,999 | 70 | 85.3% |
| Education | $343.93 | 5 | 14.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $535.56 | 7 | $0 (2019) |
| Astellas Pharma US Inc | $388.39 | 7 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $254.40 | 10 | $0 (2024) |
| Allergan Inc. | $250.26 | 18 | $0 (2017) |
| ABBVIE INC. | $144.84 | 2 | $0 (2022) |
| Eisai Inc. | $125.00 | 1 | $0 (2024) |
| Intuity Medical Inc | $124.53 | 1 | $0 (2022) |
| Takeda Pharmaceuticals America, Inc. | $123.80 | 12 | $0 (2017) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $122.19 | 1 | $0 (2022) |
| Kowa Pharmaceuticals America, Inc. | $52.56 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $207.58 | 5 | Eisai Inc. ($125.00) |
| 2023 | $432.85 | 8 | Astellas Pharma US Inc ($338.93) |
| 2022 | $270.31 | 3 | Intuity Medical Inc ($124.53) |
| 2021 | $32.96 | 2 | GlaxoSmithKline, LLC. ($19.09) |
| 2019 | $246.56 | 2 | Boehringer Ingelheim Pharmaceuticals, Inc. ($246.56) |
| 2018 | $281.19 | 5 | AbbVie, Inc. ($121.25) |
| 2017 | $871.53 | 50 | Allergan Inc. ($250.26) |
All Payment Transactions
75 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Neurology | ||||||
| 09/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Obesity | ||||||
| 04/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: Respiratory | ||||||
| 01/04/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Respiratory | ||||||
| 11/15/2023 | Astellas Pharma US Inc | — | Education | In-kind items and services | $64.95 | General |
| 11/02/2023 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: Respiratory | ||||||
| 10/19/2023 | Astellas Pharma US Inc | — | Education | In-kind items and services | $84.99 | General |
| 05/04/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/17/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/05/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $29.60 | General |
| Category: Diabetes | ||||||
| 03/16/2023 | Astellas Pharma US Inc | — | Education | In-kind items and services | $94.99 | General |
| 03/16/2023 | Astellas Pharma US Inc | — | Education | In-kind items and services | $94.00 | General |
| 12/08/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | CYCLOSET (Drug) | Food and Beverage | In-kind items and services | $122.19 | General |
| Category: Neurology | ||||||
| 09/22/2022 | Intuity Medical Inc | Pogo Automatic Blood Glucose Monitoring System (Device) | Food and Beverage | Cash or cash equivalent | $124.53 | General |
| Category: Diabetes | ||||||
| 11/05/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/15/2021 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BOOSTRIX | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: VACCINES | ||||||
| 08/01/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES | ||||||
| 03/27/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $121.56 | General |
| Category: DIABETES | ||||||
| 10/30/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $10.51 | General |
| Category: Cardiology | ||||||
| 09/08/2018 | Endo Pharmaceuticals Inc. | NASCOBAL (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: PRESCRIPTION SUPPLEMENT | ||||||
| 07/26/2018 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $121.25 | General |
| Category: Endocrinology | ||||||
| 05/15/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $10.94 | General |
| Category: Central Nervous System (CNS) | ||||||
| 04/11/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $119.42 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 590 | 1,139 | $173,430 | $79,285 |
| 2022 | 9 | 558 | 1,070 | $162,149 | $78,245 |
| 2021 | 10 | 546 | 1,026 | $158,340 | $77,560 |
| 2020 | 12 | 645 | 1,215 | $182,286 | $76,331 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 102 | 291 | $73,623 | $33,037 | 44.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 82 | 190 | $33,060 | $15,473 | 46.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 79 | 172 | $29,928 | $13,977 | 46.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 64 | 64 | $14,400 | $9,535 | 66.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 114 | 262 | $7,860 | $2,159 | 27.5% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 11 | 14 | $3,374 | $1,627 | 48.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 37 | 37 | $2,775 | $1,331 | 48.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 58 | 66 | $5,610 | $841.09 | 15.0% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 18 | 18 | $900.00 | $569.21 | 63.2% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 12 | 12 | $600.00 | $401.88 | 67.0% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 13 | 13 | $1,300 | $333.32 | 25.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 92 | 226 | $57,178 | $27,138 | 47.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 89 | 251 | $43,674 | $22,266 | 51.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 77 | 151 | $26,274 | $13,634 | 51.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 53 | 53 | $11,925 | $8,291 | 69.5% |
| 99349 | Established patient home visit, typically 40 minutes | Office | 2022 | 18 | 28 | $6,748 | $3,245 | 48.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 33 | 33 | $2,475 | $1,165 | 47.1% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2022 | 34 | 34 | $1,700 | $1,017 | 59.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 51 | 61 | $5,185 | $810.05 | 15.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 111 | 233 | $6,990 | $678.24 | 9.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 105 | 309 | $54,891 | $27,643 | 50.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 81 | 174 | $44,022 | $22,167 | 50.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 74 | 149 | $25,926 | $13,405 | 51.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 43 | 43 | $9,675 | $6,910 | 71.4% |
| 99349 | Established patient home visit, typically 40 minutes | Office | 2021 | 18 | 36 | $8,676 | $4,330 | 49.9% |
About Dr. Lori Cohen, M.D
Dr. Lori Cohen, M.D is a Internal Medicine healthcare provider based in Great Neck, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1073505103.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lori Cohen, M.D has received a total of $2,343 in payments from pharmaceutical and medical device companies, with $207.58 received in 2024. These payments were reported across 75 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,999).
As a Medicare-enrolled provider, Cohen has provided services to 2,339 Medicare beneficiaries, totaling 4,450 services with total Medicare billing of $311,421. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Great Neck, NY
- Active Since 08/16/2005
- Last Updated 06/13/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1073505103
Products in Payments
- JARDIANCE (Drug) $510.95
- FARXIGA (Drug) $166.30
- Trintellix (Drug) $134.74
- LINZESS (Drug) $129.93
- Leqembi (Drug) $125.00
- Pogo Automatic Blood Glucose Monitoring System (Device) $124.53
- CYCLOSET (Drug) $122.19
- Creon (Drug) $121.25
- BYSTOLIC (Drug) $91.18
- Myrbetriq (Drug) $49.46
- AIRSUPRA (Drug) $45.05
- SEGLENTIS (Drug) $42.08
- TRADJENTA (Drug) $32.89
- NASCOBAL (Drug) $31.97
- MOUNJARO (Drug) $29.60
- QULIPTA (Drug) $23.59
- BEVESPI AEROSPHERE (Drug) $21.87
- BREZTRI (Drug) $21.18
- NAMZARIC (Drug) $19.81
- Wegovy (Drug) $19.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Great Neck
Dr. Jamie Hirsch, Md, MD
Internal Medicine — Payments: $69,165
Joanne Lee, M.d, M.D
Internal Medicine — Payments: $36,469
Bernard Rosof
Internal Medicine — Payments: $26,679
Dr. Shahram Shamekh, Md, MD
Internal Medicine — Payments: $18,187
Sanford Ratner, M.d, M.D
Internal Medicine — Payments: $16,933
David Edelson, Md, MD
Internal Medicine — Payments: $15,163